Bayer's ALYCE - Advancing Drug Development with Data Intelligence

Explore how Bayer's Advanced Analytics Platform for the Clinical Data Environment (ALYCE) revolutionizes drug development through data intelligence in this 37-minute conference talk. Discover how ALYCE tackles rapid data growth in healthcare and life sciences using offensive and defensive data strategies, robust governance, and a tailored Lakehouse paradigm design. Learn about the platform's ability to analyze large, complex clinical data while adhering to regulations, and its use of business intelligence, AI, and machine learning to expedite clinical trial data review and enhance patient-centric study designs. Understand how ALYCE supports real-time ingestion of structured, semi-structured, and unstructured data, fostering affordable, open collaboration and empowering data-driven decision-making. Gain insights into how implementing offensive and defensive data strategies on a unique architectural platform design drives innovation, improves patient outcomes, boosts collaboration in clinical environments, and ultimately saves costs in drug development.

Bayer's ALYCE: Advancing Drug Development with Data Intelligence